Project: A Clinical Candidate for the Treatment of Rheumatoid Arthritis

This project aims to advance a first-in-class drug candidate into clinical phase for the treatment of rheumatoid arthritis (RA) and thereby improve quality of life for these patients. Through the Eurostars project we aim to improve our compounds and demonstrate that our candidates are non-toxic by using pre-clinical, in vivo and in vitro toxicity screening. To collect early clinical data a microdialysis platform will be set up for detection of biomarkers and proof-of-principle studies.

Acronym CLARA (Reference Number: 10611)
Duration 01/10/2016 - 01/10/2019
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 5

Project partner

Number Name Role Country
24661 Smerud Medical Research Oy Partner Finland
24662 Clinical Trial Consultants AB Partner Sweden
24663 Rheumatech AS Coordinator Norway